EUVIMEDEUVIMED entdecken
Crossref

Exploring marine natural products for identifying putative candidates as EBNA1 inhibitors: An insight from molecular docking, molecular dynamics, and DFT computations

Mahmoud A A Ibrahim, Alaa M A Hassan, Gamal A H Mekhemer, Peter A Sidhom, Mohamed A El-Tayeb, Ashraf M M Abdelbacki, Shahzeb Khan, Mahmoud E S Soliman, Alaa H M Abdelrahman

Biochemical and Biophysical Research Communications · 2024

DOI: 10.1016/j.bbrc.2024.150856 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biochemical and Biophysical Research Communications, 2024. Verfasst von Mahmoud A A Ibrahim und 8 weiteren Autor:innen. Beteiligte Einrichtung: Computational Chemistry Laboratory, Chemistry Department, Faculty of Science, Minia University, Minia, 61519, Egypt; School of Health Sciences, Unive…. Hauptthemen laut MEDLINE: Epstein-Barr Virus Nuclear Antigens, Molecular Docking Simulation, Biological Products, Molecular Dynamics Simulation. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 86 Literaturangaben. Gefördert von: King Saud University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Epstein-Barr virus (EBV), namely a DNA neoplasm virus, is liable for over 1 % of malignant neoplasms involving Hodgkin's and Burkitt's lymphoma as well as ventral cancer. Despite the crucial role of EBV in carcinoma evolution, no treatment has been discovered yet against EBV. Epstein-Barr nuclear antigen 1 (EBNA1), the EBV-encoded latent protein, is produced in all EBV-linked neoplasms and is the only latent protein in these cancer types. EBNA1 protein has multiple roles in the upkeep, reproduction, and EBV genome separation and can thus act as an attractive therapeutic target for treating EBV-related malignancies. In the past few decades, attempts have been made to develop specialized EBNA1 inhibitors to reduce EBNA1 expression or obstruct EBNA1-relied processes, but none has been approved yet. Marine natural products (MNPs) have garnered significant interest as potential sources of antiviral drug candidates. In seeking potent drug candidates to inhibit EBV reproduction, an MNP database containing >14,000 compounds was mined to hunt putative EBNA1 inhibitors using docking computations and molecular dynamics simulations (MDS). On the basis of binding energy (ΔGbinding) estimations over 200 ns MDS, UMHMNP351444649 and UMHMNP134128179 revealed a greater binding affinity towards EBNA1 compared to KWG, with ΔGbinding values of -35.6, -33.3, and -32.4 kcal/mol, respectively. Structural and energetical investigations of UMHMNP351444649 and UMHMNP134128179 complexed with EBNA1 were inspected, unveiling the great constancy of these inhibitors within the EBNA1 binding site. Moreover, the identified MNPs demonstrated favorable physicochemical and medicinal chemistry characteristics. Finally, density functional theory calculations were executed, and the results assured the outcomes obtained from docking computations and MDS. These findings proposed UMHMNP351444649 and UMHMNP134128179 as potential anti-EBV drug candidates that warrant further in-vitro and in-vivo assays.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Epstein-Barr Virus Nuclear AntigensMolecular Docking SimulationBiological ProductsMolecular Dynamics SimulationAntiviral AgentsHerpesvirus 4, HumanHumans

Stichwörter der Autor:innen

DFT calculationsDocking computationEBVMarine natural productmolecular dynamics simulations

Substanzen

Epstein-Barr Virus Nuclear AntigensEBV-encoded nuclear antigen 1Biological ProductsAntiviral Agents

Autor:innen und Institutionen

  • Computational Chemistry Laboratory, Chemistry Department, Faculty of Science, Minia University, Minia, 61519, Egypt; School of Health Sciences, University of KwaZulu-Natal, Westville Campus, Durban, 4000, South Africa.…
  • Computational Chemistry Laboratory, Chemistry Department, Faculty of Science, Minia University, Minia, 61519, Egypt.
  • Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Tanta University, Tanta, 31527, Egypt.
  • Department of Botany and Microbiology, College of Science, King Saud University, P.O. Box 2455, Riyadh, 11451, Saudi Arabia.
  • Deanship of Skills Development, King Saud University, P.O Box 2455, Riyadh, 11451, Saudi Arabia.
  • Centre for Pharmaceutical Engineering Science, Faculty of Life Science, School of Pharmacy and Medical Sciences, University of Bradford, BD7 1DP, UK.

Förderung

  • King Saud University

Zitieren

APA

Ibrahim, M. A. A., Hassan, A. M. A., Mekhemer, G. A. H., Sidhom, P. A., El-Tayeb, M. A., Abdelbacki, A. M. M., Khan, S., Soliman, M. E. S., & Abdelrahman, A. H. M. (2024). Exploring marine natural products for identifying putative candidates as EBNA1 inhibitors: An insight from molecular docking, molecular dynamics, and DFT computations. Biochemical and Biophysical Research Communications. https://doi.org/10.1016/j.bbrc.2024.150856

Vancouver

Ibrahim MAA, Hassan AMA, Mekhemer GAH, Sidhom PA, El-Tayeb MA, Abdelbacki AMM, et al. Exploring marine natural products for identifying putative candidates as EBNA1 inhibitors: An insight from molecular docking, molecular dynamics, and DFT computations. Biochemical and Biophysical Research Communications. 2024. doi:10.1016/j.bbrc.2024.150856

BibTeX
@article{Ibrahim2024,
  author = {Ibrahim, Mahmoud A A and Hassan, Alaa M A and Mekhemer, Gamal A H and Sidhom, Peter A and El-Tayeb, Mohamed A and Abdelbacki, Ashraf M M and Khan, Shahzeb and Soliman, Mahmoud E S and Abdelrahman, Alaa H M},
  title = {Exploring marine natural products for identifying putative candidates as EBNA1 inhibitors: An insight from molecular docking, molecular dynamics, and DFT computations},
  journal = {Biochemical and Biophysical Research Communications},
  year = {2024},
  doi = {10.1016/j.bbrc.2024.150856}
}
Kostenlos starten →